Cell and Gene Therapy
Cell and gene therapy (CGT) represents a revolutionary shift in how we treat, manage, and potentially cure a wide range of diseases—from rare genetic disorders to cancer, and beyond. By targeting the root causes of disease at the molecular level, CGTs offer hope where traditional therapies have fallen short.
Cell and Gene Therapy ELISA refers to a specialized application of ELISA technology used to:
- Quantify transgene expression (e.g., AAV-delivered proteins, CAR-T markers)
- Monitor host immune response (e.g., cytokine release, anti-drug antibodies)
- Detect impurities or residuals (e.g., host cell proteins, plasmid DNA)
- Ensure product potency and consistency
These assays are designed to meet the unique challenges of CGT workflows, from early-stage discovery to late-stage clinical trials and commercial manufacturing.
Applications Across Therapeutic Areas:
Krishgen offers a wide variety of ELISAs for estimation of CAR-T Target Proteins: